RECRUITING

Enhancing Access to Supportive Services for Women of Color with Metastatic Breast Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women with metastatic breast cancer.

Official Title

Project ACCESS: a Pilot Randomized Controlled Trial of a Navigator Delivered Model to Enhance Access to Supportive Services for Women of Color with Metastatic Breast Cancer

Quick Facts

Study Start:2024-05-01
Study Completion:2026-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06405828

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women ≥18 years of age
  2. * English and/or Spanish speaking
  3. * Self-identify as Latina and/or African American/Black
  4. * Ability to understand and the willingness to sign a written informed consent
  5. * Stage IV breast cancer diagnosis, no time component
  1. * Moderate to severe cognitive impairment
  2. * receiving inpatient hospice care
  3. * if patients were previously enrolled in Aim 1 and Aim 2
  4. * currently working with a community navigator

Contacts and Locations

Study Contact

Melissa Mazor
CONTACT
(510) 418-8642
melissa.mazor@mountsinai.org

Principal Investigator

Melissa Mazor
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Mount Sinai Hospital
New York, New York, 10029
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Melissa Mazor, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-01
Study Completion Date2026-11-30

Study Record Updates

Study Start Date2024-05-01
Study Completion Date2026-11-30

Terms related to this study

Additional Relevant MeSH Terms

  • Metastatic Breast Cancer
  • Stage IV Breast Cancer AJCC V7